TY - JOUR
T1 - The international collaborative on fatigue following infection (COFFI)
AU - Katz, Ben Z.
AU - Collin, Simon M.
AU - Murphy, Gabrielle
AU - Moss-Morris, Rona
AU - Wyller, Vegard Bruun
AU - Wensaas, Knut Arne
AU - Hautvast, Jeannine L.A.
AU - Bleeker-Rovers, Chantal P.
AU - Vollmer-Conna, Ute
AU - Buchwald, Dedra
AU - Taylor, Renée
AU - Little, Paul
AU - Crawley, Esther
AU - White, Peter D.
AU - Lloyd, Andrew
N1 - Funding Information:
The London meeting at which the COFFI collaborative was established was generously funded by the Sue Esterman Fund, a donor advised fund managed by the London Community Foundation whose website is Londoncf.org.uk. DIOS/SIOS were supported by funding from the Mason Foundation and the National Health and Medical Research Council of Australia (Project Grants 157092 and 157062) and a Cooperative Research Agreement with the US Centers for Disease Control and Prevention (U50/CCU019851-01). The prospective study of CFS following IM was funded by the National Institutes of Health (AI 105781). COFFI would also like to thank Paul Burton (University of Bristol) and Caroline Sabin (University College of London) for their presentations on data sharing and collaborative endeavors, respectively. AL is supported by a NHMRC Practitioner Fellowship (1043067).
Publisher Copyright:
© 2018 IACFS/ME.
PY - 2018/4/3
Y1 - 2018/4/3
N2 - Background: The purpose of the Collaborative on Fatigue Following Infection (COFFI) is for investigators of post-infection fatigue (PIF) and other syndromes to collaborate on these enigmatic and poorly understood conditions by studying relatively homogeneous populations with known infectious triggers. Utilising COFFI, pooled data and stored biosamples will support both epidemiological and laboratory research to better understand the etiology and risk factors for development and progression of PIF. Methods: COFFI consists of prospective cohorts from the UK, Netherlands, Norway, USA, New Zealand and Australia, with some cohorts closed and some open to recruitment. The 9 cohorts closed to recruitment total over 3000 participants, including nearly 1000 with infectious mononucleosis (IM), > 500 with Q fever, > 800 with giardiasis, > 600 with campylobacter gastroenteritis (CG), 190 with Legionnaires disease and 60 with Ross River virus. Follow-ups have been at least 6 months and up to 10 years. All studies use the Fukuda criteria for defining chronic fatigue syndrome (CFS). Results: Preliminary analyses indicated that risk factors for non-recovery from PIF included lower physical fitness, female gender, severity of the acute sickness response, and autonomic dysfunction. Conclusions: COFFI (https://internationalcoffi.wordpress.com/) is an international collaboration which should be able to answer questions based on pooled data that are not answerable in the individual cohorts. Possible questions may include the following: Do different infections trigger different PIF syndromes (e.g. CFS vs. irritable bowel syndrome)?; What are longitudinal predictors of PIF and its severity?.
AB - Background: The purpose of the Collaborative on Fatigue Following Infection (COFFI) is for investigators of post-infection fatigue (PIF) and other syndromes to collaborate on these enigmatic and poorly understood conditions by studying relatively homogeneous populations with known infectious triggers. Utilising COFFI, pooled data and stored biosamples will support both epidemiological and laboratory research to better understand the etiology and risk factors for development and progression of PIF. Methods: COFFI consists of prospective cohorts from the UK, Netherlands, Norway, USA, New Zealand and Australia, with some cohorts closed and some open to recruitment. The 9 cohorts closed to recruitment total over 3000 participants, including nearly 1000 with infectious mononucleosis (IM), > 500 with Q fever, > 800 with giardiasis, > 600 with campylobacter gastroenteritis (CG), 190 with Legionnaires disease and 60 with Ross River virus. Follow-ups have been at least 6 months and up to 10 years. All studies use the Fukuda criteria for defining chronic fatigue syndrome (CFS). Results: Preliminary analyses indicated that risk factors for non-recovery from PIF included lower physical fitness, female gender, severity of the acute sickness response, and autonomic dysfunction. Conclusions: COFFI (https://internationalcoffi.wordpress.com/) is an international collaboration which should be able to answer questions based on pooled data that are not answerable in the individual cohorts. Possible questions may include the following: Do different infections trigger different PIF syndromes (e.g. CFS vs. irritable bowel syndrome)?; What are longitudinal predictors of PIF and its severity?.
KW - Chronic fatigue syndrome
KW - Legionnaire's disease
KW - Q fever
KW - gastroenteritis
KW - infectious mononucleosis
UR - http://www.scopus.com/inward/record.url?scp=85070113829&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85070113829&partnerID=8YFLogxK
U2 - 10.1080/21641846.2018.1426086
DO - 10.1080/21641846.2018.1426086
M3 - Article
C2 - 30666281
AN - SCOPUS:85070113829
SN - 2164-1846
VL - 6
SP - 106
EP - 121
JO - Fatigue: Biomedicine, Health and Behavior
JF - Fatigue: Biomedicine, Health and Behavior
IS - 2
ER -